| Assay ID | Title | Year | Journal | Article |
|---|
| AID1347082 | qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal | 2020 | Antiviral research, 01, Volume: 173 | A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID504810 | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID1347086 | qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal | 2020 | Antiviral research, 01, Volume: 173 | A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity. |
| AID1745845 | Primary qHTS for Inhibitors of ATXN expression | | | |
| AID1347083 | qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen | 2020 | Antiviral research, 01, Volume: 173 | A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity. |
| AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | | | |
| AID504812 | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| AID338221 | Cytotoxicity against human Col1 cells | 1993 | Journal of natural products, Apr, Volume: 56, Issue:4
| Bisamides from Aglaia species: structure analysis and potential to reverse drug resistance with cultured cells. |
| AID338219 | Cytotoxicity against human LUC1 cells | 1993 | Journal of natural products, Apr, Volume: 56, Issue:4
| Bisamides from Aglaia species: structure analysis and potential to reverse drug resistance with cultured cells. |
| AID338220 | Cytotoxicity against human SK-MEL-2 cells | 1993 | Journal of natural products, Apr, Volume: 56, Issue:4
| Bisamides from Aglaia species: structure analysis and potential to reverse drug resistance with cultured cells. |
| AID338225 | Cytotoxicity against human A431 cells | 1993 | Journal of natural products, Apr, Volume: 56, Issue:4
| Bisamides from Aglaia species: structure analysis and potential to reverse drug resistance with cultured cells. |
| AID338224 | Cytotoxicity against vinblastine-resistant human KBV1 cells by dose-response study in presence of 1 ug/ml vinblastine | 1993 | Journal of natural products, Apr, Volume: 56, Issue:4
| Bisamides from Aglaia species: structure analysis and potential to reverse drug resistance with cultured cells. |
| AID338222 | Cytotoxicity against human KB cells | 1993 | Journal of natural products, Apr, Volume: 56, Issue:4
| Bisamides from Aglaia species: structure analysis and potential to reverse drug resistance with cultured cells. |
| AID338226 | Cytotoxicity against human LNCAP cells | 1993 | Journal of natural products, Apr, Volume: 56, Issue:4
| Bisamides from Aglaia species: structure analysis and potential to reverse drug resistance with cultured cells. |
| AID338223 | Cytotoxicity against vinblastine-resistant human KBV1 cells | 1993 | Journal of natural products, Apr, Volume: 56, Issue:4
| Bisamides from Aglaia species: structure analysis and potential to reverse drug resistance with cultured cells. |
| AID338227 | Cytotoxicity against human ZR-75-1 cells | 1993 | Journal of natural products, Apr, Volume: 56, Issue:4
| Bisamides from Aglaia species: structure analysis and potential to reverse drug resistance with cultured cells. |
| AID338217 | Cytotoxicity against human BCA1 cells | 1993 | Journal of natural products, Apr, Volume: 56, Issue:4
| Bisamides from Aglaia species: structure analysis and potential to reverse drug resistance with cultured cells. |
| AID338218 | Cytotoxicity against human HT1080 cells | 1993 | Journal of natural products, Apr, Volume: 56, Issue:4
| Bisamides from Aglaia species: structure analysis and potential to reverse drug resistance with cultured cells. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |